The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection

Purpose. The purpose of the study was to assess the results of the proposed method of surgical treatment of massive subretinal macular hemorrhage in the wet form of age-r elated macular degeneration.Material and methods. A comparative study of the results of treatment of massive subretinal hemorrhag...

Full description

Bibliographic Details
Main Authors: A. D. Ovchinnikova, A. V. Mironov, T. O. Dulgieru
Format: Article
Language:Russian
Published: Publishing house "Ophthalmology" 2021-01-01
Series:Офтальмохирургия
Subjects:
amd
Online Access:https://www.ophthalmosurgery.ru/jour/article/view/687
id doaj-db136cbd4f724d21afedf12f219669ac
record_format Article
spelling doaj-db136cbd4f724d21afedf12f219669ac2021-07-28T13:53:41ZrusPublishing house "Ophthalmology"Офтальмохирургия0235-41602312-49702021-01-0104434910.25276/0235-4160-2020-4-43-49479The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injectionA. D. Ovchinnikova0A. V. Mironov1T. O. Dulgieru2The S. Fyodorov Foundation to promote the development of advanced medical technologyThe S. Fyodorov Foundation to promote the development of advanced medical technologyThe S. Fyodorov Foundation to promote the development of advanced medical technologyPurpose. The purpose of the study was to assess the results of the proposed method of surgical treatment of massive subretinal macular hemorrhage in the wet form of age-r elated macular degeneration.Material and methods. A comparative study of the results of treatment of massive subretinal hemorrhage associated with the exudative AMD-related. 17 patients (17 eyes) were being observed in the clinic with submacular hemorrhages of varying severity, which occurred against the background of exudative AMD-related. The average age of the subjects was 71.47±6.15 years. The maximum corrected visual acuity at the time of admission averaged 0,04±0.03. All patients were previously treated with anti-VEGF therapy, and number intravitreal injections was in the range from 3 to 14. The experience of the disease was 2,35±0,77 years, the prescription of hemorrhage – 5,47±3,55 days. The mean size of the subretinal hemorrhage was 21.41±3.37 DD. According to optical coherence tomography, the average value of retinal thickness in the macular region was 1081,29±389,67 microns. The day before surgery all patients underwent surgical treatment according to the author’s method (patent No. 2696056) – intravitreal injection Gemase® 3000 ME, 0,2 ml. The next day was performed vitrectomy 25G, local removal of the ILM and subretinal injection Gemase® 3000 ME – 0.3 ml and 0.2 ml of sterile air, fluid-air exchange 70% of the volume vitreal cavity, intravitreal injection Eylea® 0.05 ml, tamponade of vitreous cavity with 20% SF6. After the operation, the patient was placed «horizontally on the back» for 2 hours, then he had to be in an upright position to move the blood clot to the lower parts of the ocular floor .Results. Intraoperative complications were not observed in any of the cases. A complete dislocation of subretinal hemorrhage from under fovea zone was achieved in every patient’s postoperative period.Conclusion. The proposed surgical method provides rapid recovery of subject vision and can be used in the treatment of massive submacular hemorrhages of any etiology.https://www.ophthalmosurgery.ru/jour/article/view/687amdsubmacular hemorrhagesvitrectomyprourokinase
collection DOAJ
language Russian
format Article
sources DOAJ
author A. D. Ovchinnikova
A. V. Mironov
T. O. Dulgieru
spellingShingle A. D. Ovchinnikova
A. V. Mironov
T. O. Dulgieru
The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
Офтальмохирургия
amd
submacular hemorrhages
vitrectomy
prourokinase
author_facet A. D. Ovchinnikova
A. V. Mironov
T. O. Dulgieru
author_sort A. D. Ovchinnikova
title The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
title_short The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
title_full The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
title_fullStr The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
title_full_unstemmed The surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of AMD with automated subretinal injection
title_sort surgical treatment of massive submacular hemorrhages aggravating the course of exudative form of amd with automated subretinal injection
publisher Publishing house "Ophthalmology"
series Офтальмохирургия
issn 0235-4160
2312-4970
publishDate 2021-01-01
description Purpose. The purpose of the study was to assess the results of the proposed method of surgical treatment of massive subretinal macular hemorrhage in the wet form of age-r elated macular degeneration.Material and methods. A comparative study of the results of treatment of massive subretinal hemorrhage associated with the exudative AMD-related. 17 patients (17 eyes) were being observed in the clinic with submacular hemorrhages of varying severity, which occurred against the background of exudative AMD-related. The average age of the subjects was 71.47±6.15 years. The maximum corrected visual acuity at the time of admission averaged 0,04±0.03. All patients were previously treated with anti-VEGF therapy, and number intravitreal injections was in the range from 3 to 14. The experience of the disease was 2,35±0,77 years, the prescription of hemorrhage – 5,47±3,55 days. The mean size of the subretinal hemorrhage was 21.41±3.37 DD. According to optical coherence tomography, the average value of retinal thickness in the macular region was 1081,29±389,67 microns. The day before surgery all patients underwent surgical treatment according to the author’s method (patent No. 2696056) – intravitreal injection Gemase® 3000 ME, 0,2 ml. The next day was performed vitrectomy 25G, local removal of the ILM and subretinal injection Gemase® 3000 ME – 0.3 ml and 0.2 ml of sterile air, fluid-air exchange 70% of the volume vitreal cavity, intravitreal injection Eylea® 0.05 ml, tamponade of vitreous cavity with 20% SF6. After the operation, the patient was placed «horizontally on the back» for 2 hours, then he had to be in an upright position to move the blood clot to the lower parts of the ocular floor .Results. Intraoperative complications were not observed in any of the cases. A complete dislocation of subretinal hemorrhage from under fovea zone was achieved in every patient’s postoperative period.Conclusion. The proposed surgical method provides rapid recovery of subject vision and can be used in the treatment of massive submacular hemorrhages of any etiology.
topic amd
submacular hemorrhages
vitrectomy
prourokinase
url https://www.ophthalmosurgery.ru/jour/article/view/687
work_keys_str_mv AT adovchinnikova thesurgicaltreatmentofmassivesubmacularhemorrhagesaggravatingthecourseofexudativeformofamdwithautomatedsubretinalinjection
AT avmironov thesurgicaltreatmentofmassivesubmacularhemorrhagesaggravatingthecourseofexudativeformofamdwithautomatedsubretinalinjection
AT todulgieru thesurgicaltreatmentofmassivesubmacularhemorrhagesaggravatingthecourseofexudativeformofamdwithautomatedsubretinalinjection
AT adovchinnikova surgicaltreatmentofmassivesubmacularhemorrhagesaggravatingthecourseofexudativeformofamdwithautomatedsubretinalinjection
AT avmironov surgicaltreatmentofmassivesubmacularhemorrhagesaggravatingthecourseofexudativeformofamdwithautomatedsubretinalinjection
AT todulgieru surgicaltreatmentofmassivesubmacularhemorrhagesaggravatingthecourseofexudativeformofamdwithautomatedsubretinalinjection
_version_ 1721270193915691008